Expanded Access With COVID Therapeutics Were ‘Worst-Case Scenario’ For Informed Consent

 
• By Sue Sutter
Foot in door
Expanded access programs allow patients to get a foot in the door for investigational therapies when clinical trials are not available. • Source: Alamy

More from Rare Diseases

More from Pink Sheet